Fintech ‘unicorn’ Numbrs slashes jobs as investors turn tail
Numbrs has a custom-made premises in Zurich to house its HQ.
All Rights Reserved
The mobile banking app Numbrs is poised to cut 62 of its Zurich-based staff after investors pulled out of an agreement to inject new funds into the company. Just last year, the fintech firm said it was worth CHF1 billion having attracted big ticket investments from around the world.
This content was published on
2 minutes
When not covering fintech, cryptocurrencies, blockchain, banks and trade, swissinfo.ch's business correspondent can be found playing cricket on various grounds in Switzerland - including the frozen lake of St Moritz.
The digital finance platform employs around 150 staff at its headquarters in Zurich. Operating mainly in the German market, Numbrs had raised $200 million (CHF195 million) in previous funding rounds despite failing to make an annual profit since its inception in 2014.
But the company now faces a painful restructuring period because “a new round of financing in the high double-digit million range has not materialized despite a legally binding signature”. The company did not name the proposed investors or say whether they had pulled out due to the economic uncertainties created by coronavirus.
As a result of the blow, Numbrs says it must now reduce fixed costs, such as staff wages, by 50%. But the company is going ahead with plans to enter the British market.
“I would like to ask all Numbrs employees for understanding that, like many other startups, we now have to prepare for a longer dry spell,” stated managing partner Fynn Kreuz.
The coronavirus pandemic has negatively impacted venture capital funding as the economy and financial markets have been thrown into turmoil. Several investors have seen their own wealth shrink and are concentrating on keeping their current portfolio of start-ups afloat rather than risking new investments.
This content was published on
Potentially toxic arsenic compounds can form in the human body when seafood is consumed. This is caused by arsenobetaine, which is often found in seafood. It can be converted into partially toxic substances by intestinal bacteria.
This content was published on
Swiss retailer Coop is expanding its programme to avoid meat waste. A corresponding pilot project is gradually being extended to the entire store network.
This content was published on
Women and foreign nationals are rarely found on the boards of directors of Swiss small and medium-sized businesses (SMEs).
Almost 700,000 people moved house in Switzerland in 2023
This content was published on
In Switzerland, 9.3% of the population moved in 2023. This was the lowest rate in over ten years, the Federal Statistical Office (FSO) said on Monday.
New trial in Zurich for lawyer in ‘cum-ex’ scandal
This content was published on
German lawyer Eckart Seith, considered in Germany to be the whistleblower in the cum-ex transaction scandal, is set to appear for trial again in Switzerland on Monday.
Swiss Federal Railways rated second best in Europe
This content was published on
The best railway company in Europe is Trenitalia, according to NGO Transport and Environment (T&E). Swiss Federal Railways came second.
Berset: ‘Democracy is regressing in several countries’
This content was published on
Democracy is backsliding in a number of nations and needs to be strengthened, says Alain Berset, secretary general of the Council of Europe.
Fall of Assad: Switzerland calls for reconciliation in Syria
This content was published on
Following the fall of Bashar al-Assad's regime in Syria, the Swiss foreign ministry has called on all parties to protect civilians and respect international humanitarian law.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss fintech scene on the verge of a ‘big decade’
This content was published on
The number of financial technology start-ups is rapidly growing in Switzerland, as is the amount of funding they receive from venture capitalists.
Swiss venture capital funding breaks CHF2 billion barrier
This content was published on
New ventures in the ICT and fintech sectors received the largest slice of funding (CHF1.2 billion), but financial support for early stage biotech firms also received a significant boost (CHF625 million), according to the annual reportExternal link from online news portal startupticker.chExternal link and the investor association SECAExternal link. Four Swiss companies – ADC Therapeutics,…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.